Management

Per Andersson

Chief Executive Officer

Chief Executive Officer at Xspray Pharma since 2006
Born 1967

Per has a background as Science Director at Gyros Protein Therapeutics AB, where he developed a completely new ground-breaking technology into something that is now profitable products. He has over 200 patents as an inventor and successfully worked in patent strategy for more than 25 years. Previously, he worked as a senior scientist at Cytiva AB, where he focused on technological innovation. Per is co-author of over 30 scientific publications.

Education: Ph.D. in Analytical Chemistry, Stockholm university

Other current activities: CEO of Xspray Pharma Inc., Chairman of the board of Robotic Lawn Care Sweden AB and Xspray Pharma Futurum AB, and deputy board member in Journeyman Stockholm AB

Holdings: 197,810 shares and 310,923 options of which 103,641 warrants and 207,282 employee stock options.

Independent in relation to the larger shareholders but not in relation to the company

Anette Abrahamsson

Senior Vice President Regulatory Affairs

Senior Vice President Regulatory Affairs at Xspray Pharma since 2021
Born 1969

Anette has more than 25 years of experience from the pharmaceutical industry and has held positions within Regulatory Affairs, Drug Safety and Quality Assurance. Her experience reaches from Nordic to international responsibilities, within small and big pharmaceutical companies such as AstraZeneca, Pfizer, Unimedic Pharma, Karo Pharma and Cederroth. Anette has also had senior consultancy roles at Pharma Relations.

Education: M.Sc. Pharm, Uppsala University

Other current activities: –

Holdings in the Company: 1,675 shares and 43,548 options of which 14,516 warrants and 29,032 employee stock options.

Independent in relation to major shareholders but not in relation to the Company.

Niklas Adenborg

Chief Financial Officer since 2024

Born 1992

Niklas has extensive finance and auditing experience, and has previously been auditor at KPMG. Niklas joined Xspray Pharma 2019 and has previous held roles as Financial Controller and Finance Director.

Education: Bachelor of Science in Business and Economics, Uppsala University

Other current activities: Other current activities: Board Member of Brf Flöjtblåsaren 7

Holdings in the Company: 1,394 shares and 50,256 options of which 16,756 warrants and 33,500 employee stock options

Independent in relation to major shareholders but not in relation to the Company

Linda Glimberg

Chief Operating Officer

Chief Operating Officer at Xspray Pharma since 2024
Born 1974

Linda has worked as a lawyer for more than 25 years of which more than 15 years as an in-house counsel at international companies. Since 2018 she has been running her own consultancy firm providing business legal advice, focusing on the life science sector. She has held various leading positions at AstraZeneca, Husqvarna and Keolis.

Education: Master of Laws (LLM), Uppsala University. Master of Laws (LLM) Cambridge University, England

Other current activities: Owner and Board Member of Glimberg Holding AB and Glimberg Consulting AB, Board Member of Robotic Lawn Care Sweden AB.

Holdings in the Company: 2,000 shares via Company and 10,026 options of which 3,342 warrants and 6,684 employee stock options.

Independent in relation to major shareholders but not in relation to the Company.

Kerstin Hasselgren

Senior Advisor & Investor Relations

Born 1961

Kerstin Hasselgren has broad experience from working in large public international companies as VP Corporate Business Control at SSAB, CFO at Alstom Transport Nordic, VP Finance Global Operations at AstraZeneca and VP Finance Global R&D at AstraZeneca

Education: M.Sc. Business Administration, Stockholm School of Economics

Other current activities: –

Holdings in the Company: 9,164 shares and 82,750 options of which 40,250 warrants and 42,500 employee stock options.

Independent in relation to major shareholders but not in relation to the Company

Christer Hällgren

Senior Vice President Intellectual Property

Senior Vice President Intellectual Property at Xspray Pharma since 2018
Born 1962

Christer has more than 25 years of experience from the pharmaceutical industry.

Education: European Patent Attorney, Ph.D. Organic Chemistry, Stockholm University

Other current activities: –

Holdings in the Company: 31,000 shares and 61,155 options of which 20,385 warrants and 40,770 employee stock options.

Independent in relation to major shareholders but not in relation to the Company.


Edward Jordan

Chief Commercial Officer

Chief Commercial Officer at Xspray Pharma since 2023
Born 1967

Edward has extensive global biopharma commercial and operational experience having launched multiple products and commercial organizations.

Education: BS, Insurance and Finance, University of Rhode Island. MBA, Southern University of New Hampshire

Other current activities: –

Holdings in the company: –

Independent in relation to major shareholders but not in relation to the Company.

Charlotta Liljebris

Senior Vice President Research and Development

Senior Vice President Research and Development at Xspray Pharma since 2018
Born 1964

Charlotta Liljebris has 30 years of experience from the pharmaceutical industry. She has been responsible for the project portfolio and business development at Orexo, VP R&D at Aprea with focus on oncology and worked in several leading positions within project management at Biovitrum.

Education: Ph.D. in Medicinal Chemistry, Uppsala University, Sweden
M.Sc. in Chemistry, Uppsala University, Sweden

Other current activities: –

Holdings in the Company: 3,333 shares and 56,265 options of which 18,755 warrants and 37,510 employee stock options.

Independent in relation to major shareholders but not in relation to the Company.